✦ LIBER ✦

Phase I study of bevacizumab combined with irinotecan and S-1 as second-line chemotherapy in patients with advanced colorectal cancer

✍ Scribed by Hitoshi Kusaba, Taito Esaki, Junji Kishimoto…

Book ID: 120776574
Publisher: Springer
Year: 2012
Tongue: English
Weight: 179 KB
Volume: 71
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-012-2023-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of combined chemotherapy

Phase II study of combined chemotherapy with irinotecan and S-1 (IRIS) plus bevacizumab in patients with inoperable recurrent or advanced colorectal cancer

✍ Komatsu, Yoshito; Yuki, Satoshi; Sogabe, Susumu; Fukushima, Hiraku; Nakatsumi, H 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 104 KB

6049 Phase II trial of combined chemothe

6049 Phase II trial of combined chemotherapy with irinotecan, S-1, and bevacizumab in patients with metastatic colorectal cancer

✍ Hatanaka, K.; Komatsu, Y.; Yuki, S.; Nakamura, M.; Miyagishima, T.; Kudo, M.; Mu 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Phase I trial of weekly irinotecan combi

Phase I trial of weekly irinotecan combined with UFT as second-line treatment for advanced colorectal cancer

✍ V Alonso; P Escudero; M Zorrilla; M.D Isla; A Herrero; J.I Mayordomo; J Martinez 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 105 KB

Effects of bevacizumab on plasma concent

Effects of bevacizumab on plasma concentration of irinotecan and its metabolites in advanced colorectal cancer patients receiving FOLFIRI with bevacizumab as second-line chemotherapy

✍ Yosuke Horita; Y. Yamada; Y. Hirashima; K. Kato; T. Nakajima; T. Hamaguchi; Y. S 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 529 KB

A phase I study of combination therapy w

A phase I study of combination therapy with S-1 and irinotecan (CPT-11) in patients with advanced colorectal cancer

✍ Manabu Shiozawa; Nobuhiro Sugano; Kazuhito Tsuchida; Soichiro Morinaga; Makoto A 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 296 KB

Phase II study of irinotecan as first-li

Phase II study of irinotecan as first-line chemotherapy for patients with advanced colorectal carcinoma

✍ José Luis Fírvida; Antonio Irigoyen; Sergio Vázquez-Estévez; Pilar Díz; Manuel C 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB 👁 2 views